CompletedNot Applicable

Mitral Valve Management During Septal Myectomy

Russia48 participantsStarted 2016-01-10

Plain-language summary

Objective of the study: to evaluate whether alfieri technique improves clinical and hemodynamic results compared to transaortic mitral valve secondary cord cutting in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hypertrophic obstructive cardiomyopathy * Left ventricle outflow tract gradient \> 50 mm Hg at rest * Systolic anterior motion mediated mitral regurgitation Exclusion Criteria: * Intrinsic valvular heart disease * Coronary artery disease * Aortic disease

What they're measuring

Transmitral pressure gradient

Timeframe: 30-days

Trial details

NCT IDNCT03906734

SponsorMeshalkin Research Institute of Pathology of Circulation

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2016-10-28

View on ClinicalTrials.gov More Hypertrophic Cardiomyopathy trials